Equipoise remains a major consideration in the ethical evaluation of Phase 3 Randomized Controlled Trials involving precision oncology approaches in NSCLC

Sarah Heynemann; Wendy Lipworth; Sue Anne McLachlan; Jennifer Philip; Tom John; Ian Kerridge

doi:10.1016/j.jtho.2024.07.004

Equipoise remains a major consideration in the ethical evaluation of Phase 3 Randomized Controlled Trials involving precision oncology approaches in NSCLC

Sarah Heynemann^*, Wendy Lipworth, Sue Anne McLachlan, Jennifer Philip, Tom John, Ian Kerridge

^*Corresponding author for this work

Department of Philosophy

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1504-1508
Number of pages	5
Journal	Journal of Thoracic Oncology
Volume	19
Issue number	11
DOIs	https://doi.org/10.1016/j.jtho.2024.07.004
Publication status	Published - Nov 2024

Access to Document

10.1016/j.jtho.2024.07.004

Cite this

@article{48620f9806d04451b6d2ebaff70f5351,

title = "Equipoise remains a major consideration in the ethical evaluation of Phase 3 Randomized Controlled Trials involving precision oncology approaches in NSCLC",

author = "Sarah Heynemann and Wendy Lipworth and McLachlan, {Sue Anne} and Jennifer Philip and Tom John and Ian Kerridge",

year = "2024",

month = nov,

doi = "10.1016/j.jtho.2024.07.004",

language = "English",

volume = "19",

pages = "1504--1508",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Lippincott Williams & Wilkins",

number = "11",

}

TY - JOUR

T1 - Equipoise remains a major consideration in the ethical evaluation of Phase 3 Randomized Controlled Trials involving precision oncology approaches in NSCLC

AU - Heynemann, Sarah

AU - Lipworth, Wendy

AU - McLachlan, Sue Anne

AU - Philip, Jennifer

AU - John, Tom

AU - Kerridge, Ian

PY - 2024/11

Y1 - 2024/11

UR - http://www.scopus.com/inward/record.url?scp=85206478092&partnerID=8YFLogxK

UR - http://purl.org/au-research/grants/nhmrc/GNT2021953

U2 - 10.1016/j.jtho.2024.07.004

DO - 10.1016/j.jtho.2024.07.004

M3 - Article

C2 - 39510704

AN - SCOPUS:85206478092

SN - 1556-0864

VL - 19

SP - 1504

EP - 1508

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 11

ER -

Equipoise remains a major consideration in the ethical evaluation of Phase 3 Randomized Controlled Trials involving precision oncology approaches in NSCLC

Access to Document

Other files and links

Cite this